<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382001</url>
  </required_header>
  <id_info>
    <org_study_id>PROTOCOL-1196</org_study_id>
    <nct_id>NCT04382001</nct_id>
  </id_info>
  <brief_title>Heart Rate Variability During the Menstrual Cycle</brief_title>
  <official_title>Further Investigations of Heart Rate Variability During the Menstrual Cycle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SPD Development Company Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SPD Development Company Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, women will be required to wear a chest heart rate monitor and wrist heart rate&#xD;
      monitor daily and collect daily early morning urine samples for the duration of one complete&#xD;
      menstrual cycle. This will enable comparisons between data collected from the heart rate&#xD;
      monitor and hormone analysis in urine samples to be made.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective observational study of women's heart rate and heart rate&#xD;
      variability throughout one complete menstrual cycle. A minimum of 10 volunteers aged 18 years&#xD;
      of age or over will be recruited via a variety of methods according to the criteria detailed&#xD;
      in section 9. They will be required to wear a chest heart rate monitor and wrist heart rate&#xD;
      monitor for 1 hour each day, and throughout the night for one menstrual cycle. In addition, a&#xD;
      daily early morning urine sample will be collected throughout the study.&#xD;
&#xD;
      Urine samples will be returned to SPD on a regular basis for measurement of urinary hormones&#xD;
      related to pregnancy and fertility. Data collected via the monitors including heart rate and&#xD;
      heart rate variability will be downloaded for comparison.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">May 6, 2021</completion_date>
  <primary_completion_date type="Actual">May 6, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate</measure>
    <time_frame>1 month</time_frame>
    <description>Heart rate at time points throughout the menstrual cycle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>1 month</time_frame>
    <description>Heart rate variability at time points throughout the menstrual cycle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Day of Ovulation</measure>
    <time_frame>1 month</time_frame>
    <description>Day of ovulation determined by urinary LH surge +1 day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fertile Window</measure>
    <time_frame>1 month</time_frame>
    <description>Fertile window onset determined by E3G surge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fertile window</measure>
    <time_frame>1 month</time_frame>
    <description>Fertile window closure determined by P3G rise</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparisons between wrist and chest band monitors</measure>
    <time_frame>1 month</time_frame>
    <description>Agreement between wrist band and chest band heart rate data</description>
  </secondary_outcome>
  <enrollment type="Actual">28</enrollment>
  <condition>Ovulation</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years of age and over&#xD;
&#xD;
          -  Regular menstrual cycles (23-35 days in length)-&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taking any hormonal medications&#xD;
&#xD;
          -  Taking any medications that may affect heart rate&#xD;
&#xD;
          -  Known heart condition or use of a pacemaker&#xD;
&#xD;
          -  Skin condition where there is sensitivity to wearing a skin monitor&#xD;
&#xD;
          -  Currently suffering with anxiety or panic attacks&#xD;
&#xD;
          -  Pregnant or breastfeeding&#xD;
&#xD;
          -  Undertaking any frequent travel or long-haul flights during the course of the study&#xD;
&#xD;
          -  Does not have access to an Apple iPhone or iPad with Bluetooth 4.0 (or later) and iOS&#xD;
             10.0 (or later)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Adult female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Sarah Johnson</last_name>
    <role>Study Director</role>
    <affiliation>SPD Development Company</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SPD Development Company Ltd</name>
      <address>
        <city>Bedford</city>
        <state>Bedfordshire</state>
        <zip>MK44 3UP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

